hemotune AG
🇨ðŸ‡Switzerland
- Country
- 🇨ðŸ‡Switzerland
- Ownership
- Holding
- Established
- 2016-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.hemotune.ch
First in Human Trial to Assess the Feasibility and Preliminary Safety of Adjunctive Treatment with the HemoSystem REBOOT in Critically Ill Patients with Sepsis-induced Immunosuppression
Not Applicable
Not yet recruiting
- Conditions
- Septic Shock
- Interventions
- Device: Hemosystem REBOOT
- First Posted Date
- 2024-02-14
- Last Posted Date
- 2025-03-14
- Lead Sponsor
- hemotune AG
- Target Recruit Count
- 16
- Registration Number
- NCT06258291
- Locations
- 🇨ðŸ‡
University Hospital Zurich, Zurich, Switzerland
🇨ðŸ‡University Hospital Bern Inselspital, Bern, Switzerland
© Copyright 2025. All Rights Reserved by MedPath